Deborah Morosini
Director/Board Member bei National Comprehensive Cancer Network Foundation
Profil
Deborah Morosini gründete AstraZeneca Pharmaceuticals LP. Sie ist Chief Clinical Affairs Officer & Executive VP bei Prelude Therapeutics, Inc. Außerdem ist sie im Vorstand der National Comprehensive Cancer Network Foundation und von Clinwiki. In der Vergangenheit war sie VP-Clinical Affairs & Patient Engagement bei Loxo Oncology, Inc. und VP-Clinical Affairs & Patient Engagement bei Foundation Medicine, Inc. sowie Pathology Director bei Ardais Corp. Deborah Morosini erwarb einen Bachelor-Abschluss am Mount Holyoke College, einen Master-Abschluss an der New York University School of Social Work und einen Doktortitel an der Boston University School of Medicine.
Aktive Positionen von Deborah Morosini
| Unternehmen | Position | Beginn |
|---|---|---|
| National Comprehensive Cancer Network Foundation | Director/Board Member | - |
| Clinwiki | Director/Board Member | - |
Ehemalige bekannte Positionen von Deborah Morosini
| Unternehmen | Position | Ende |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Chief Tech/Sci/R&D Officer | 06.04.2022 |
| LOXO ONCOLOGY INC | Chief Tech/Sci/R&D Officer | 01.04.2019 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01.04.2016 |
Ardais Corp.
 Ardais Corp. Information Technology ServicesTechnology Services Ardais Corp. provides web-based software solutions for the healthcare industry. The company is based in Lexington, MA. The company was founded by Eric B. Gordon, Alan J. Buckler, Martin Ferguson, Heidi R. Wyle. Ardais was acquired by HealthCare IT, Inc. on December 31, 2006. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Founder | - |
Ausbildung von Deborah Morosini
| Mount Holyoke College | Undergraduate Degree |
| New York University School of Social Work | Graduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
Ardais Corp.
Ardais Corp. Information Technology ServicesTechnology Services Ardais Corp. provides web-based software solutions for the healthcare industry. The company is based in Lexington, MA. The company was founded by Eric B. Gordon, Alan J. Buckler, Martin Ferguson, Heidi R. Wyle. Ardais was acquired by HealthCare IT, Inc. on December 31, 2006. | Technology Services |
| National Comprehensive Cancer Network Foundation | |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
| Clinwiki |
